Lars Björck
11 – 20 of 135
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots
(
- Contribution to journal › Article
-
Mark
Human igg increases virulence of streptococcus pyogenes through complement evasion
(
- Contribution to journal › Article
-
Mark
Protein SIC secreted from Streptococcus pyogenes forms complexes with extracellular histones that boost cytokine production
(
- Contribution to journal › Article
-
Mark
Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
(
- Contribution to journal › Article
- 2017
-
Mark
Toward clinical use of the IgG specific enzymes IdeS and EndoS against antibody-mediated diseases
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury
(
- Contribution to journal › Article
- 2016
-
Mark
Structure and Interactions of a Dimeric Variant of sHIP, a Novel Virulence Determinant of Streptococcus pyogenes.
(
- Contribution to journal › Article
-
Mark
Saliva-Induced Clotting Captures Streptococci : Novel Roles for Coagulation and Fibrinolysis in Host Defense and Immune Evasion
(
- Contribution to journal › Article
- 2015
-
Mark
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.
(
- Contribution to journal › Article
-
Mark
Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.
(
- Contribution to journal › Article